the issue isn't IP, it's the small cartel of manufacturers
-
-
-
I mean if the question is "why is it hard/capital-intensive to set up a new insulin production line" I haven't got a clue, but AFAIK the basic problem is that everyone who has one going now is in a cartel
-
Can it be imported from China or India?
-
if the FDA didn't basically ban the import of all drugs from everywhere none of this cartel pricing stuff would work at all
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.